In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1896 News Items found
Physician-scientist Alex Kentsis
In the Lab
Research Shows How Common Feature of Blood Cancers Can Be Targeted

Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
Direna Alonso Curbelo
Sloan Kettering Institute Scientists Learn How Genes and Environment Conspire in Pancreatic Cancer Development

The insights lay the groundwork for earlier diagnosis and better treatment of the disease.
Memorial Sloan Kettering, City College of New York Awarded $4M NIH Grant to Study the Use of Machine Learning in Early Breast Cancer Detection

Memorial Sloan Kettering and the City College of New York (CCNY) were recently awarded a $4 million grant from the National Institutes of Health to study the use of machine learning for early breast cancer detection in high-risk women.
Dr. Bob Li
Medical Oncologist Bob Li Featured in the Presidential Symposium at the 2020 World Conference on Lung Cancer

Dr. Bob Li will present registrational phase II data from the first-ever trial of a drug that blocks cancer gene KRAS.
MSK immunologist Ming Li
Sloan Kettering Institute Scientists Solve a 100-Year-Old Mystery about Cancer

Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.
Lorenz Studer and Viviane Tabar
Upcoming Clinical Trial Will Test New Cell Therapy for Parkinson’s Disease in Humans

Study will be the first clinical trial testing an investigational stem cell therapy aimed at restoring lost brain cells called neurons in people with advanced Parkinson’s disease (PD).
Vijai Joseph and Sabine Topka in the lab
Finding
Repairing DNA Damage in Cancer Cells

New findings could lead to a different kind of cancer drug that targets a DNA damage repair pathway called nucleotide excision repair.
Francisco Sánchez-Rivera
Confronting a Crisis: How MSK Cancer Geneticists Responded to COVID-19

During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists.
Martin S. Tallman, MD
Memorial Sloan Kettering’s Martin S. Tallman, MD, Named American Society of Hematology President

Dr. Tallman will serve a year-long term as President for the American Society of Hematology.
Pediatric oncologist Nai-Kong Cheung
Novel Treatment Pioneered by MSK Kids Researchers Receives FDA Approval for Patients with High-Risk Neuroblastoma

The US Food and Drug Administration (FDA) has approved the drug naxitamab (Danyelza) for the treatment of patients with high-risk neuroblastoma. The drug, also known as humanized 3F8, was developed by researchers at MSK Kids, the pediatric cancer program at Memorial Sloan Kettering.